ALS (Lou Gehrig's Disease) clinical trials
99 active trials name this condition (recorded in the registry as “Amyotrophic Lateral Sclerosis”) . Describe your situation to see which ones look like a fit.
Refine by biomarker
By location
- Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- Tongue-strengthening Exercises in People With ALS.
- Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
- Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
- Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Tofersen in Non-SOD1 ALS
- Study of COYA 302 for the Treatment of ALS
- Combined Respiratory Training in Persons With ALS
- RAPA-501 Therapy for ALS
- AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
- Intestinal Microbiome Transplant in ALS
- Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
- Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
- A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)
- Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- A Study of Ranolazine in ALS
- Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis
- Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
- Neurologic Stem Cell Treatment Study
- Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- PET Tau - Neurodegenerative Disease Imaging
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth
- A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
- ALS Research Collaborative
- Multicenter ALS Imaging Study
- PREVENT ALL ALS Study
- ASSESS ALL ALS Study
- EIM Via the Myolex mScan as an ALS Biomarker
- Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
- Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- Intermuscular Coherence as a Biomarker for ALS
- Analysis of Human ALS Tissues and Registry of ALS Patients
- Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
- Amyotrophic Lateral Sclerosis (ALS) Families Project
- Imaging Biomarkers in ALS
- The National Amyotrophic Lateral Sclerosis Registry
- The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
- Clinical Research in ALS Study
- Healing ALS Registry Observational Study (HAROS)
- Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
- AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
- Clinical Procedures to Support Research in ALS
- FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Amyotrophic Lateral Sclerosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.